BioCatalyst

AB-2100 — catalyst calendar

1 verified catalyst event(s) referencing AB-2100, each linked to its official source. Verified as of 2026-11-03.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-12-31
in 2mo
ESTIMATED
 READOUT
AB-2100, an Integrated Circuit T Cell Therapy in Patients With Recurrent Clear-c
Phase 1/2 · Advanced/Metastatic Clear Cell Renal Cell Carcinoma, Recurrence
 Arsenal Biosciences, Inc. AB-2100 ClinicalTrials.gov ↗
✓ Source-checked 2026-11-03
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.